BAT Science - News and Conferences

Quick Navigation

Jump to content

News and Conferences

Latest News

25 October 2017 - Vapour from glo™ had little or no biological impact on cells in laboratory tests

Papers 5, 6, and 7 of the glo Special Issue detail the studies of the biological in vittro effects that glo vapour has on human cells.

30 May 2017 - Tobacco hybrid emits low-toxicant, e-cig-like vapour with enhanced flavour

Scientists tested vapour produced by a hybrid tobacco device, iFuse, and compared it to that produced by an e-cigarette, Vype ePen

16 May 2017 - BAT leads the way in e-cig safety testing with new screening technique

Scientists at British American Tobacco have developed a technique that can detect unpredicted substances in e-cigarette vapour.

02 May 2017 - Making e-cigarettes allergy free: a practical guide

The first practical guide to the allergy-safe use of ingredients, such as flavourings, in e-liquid has been published.

27 April 2017 - e-cigarette vapour does not promote cancer growth in lab-based tests

A new study found no evidence that vapour from a commercially available e-cigarette promotes the development of cancer in laboratory cells. In contrast, smoke from a reference cigarette was positive for cancer-promoting activity, even at very low concentrations.

18 April 2017 - Acute exposure to Vype vapor has limited impact on gene expression in human lung cells

New research shows that at equivalent or higher doses of nicotine, acute exposure to e-cigarette vapour has very limited impact on gene expression compared to cigarette smoke.

29 March 2017 - Baltimore beckons BAT scientists for key international tox conference

Top scientists from BAT headed to Maryland, USA to present new research at the Society of Toxicology (SOT) Annual Meeting.

24 March 2017 - A new tool to predict the potential public health benefit of e-cigarettes

A new study predicts that when e-cigarettes are available as alternative to cigarettes, by 2050 the 32% of smokers in the UK that otherwise would have continued smoking would have completely switched to e-cigarettes.

21 March 2017 - Spotlight on "nicotine in all its manifestations" - BAT  shares science at SRNT

Key scientists from British American Tobacco (BAT) presented their latest research at the Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting in Florence, Italy earlier this month.

11 March 2017 - Glo, a tobacco-heating product, has significantly less impact on indoor air quality than cigarettes

New research indicates that glo, a commercial tobacco heating product (THP), has less of an impact on indoor air quality than cigarette smoke.

10 March 2017 - Citric acid has the potential to produce respiratory sensitisers in e-cigarette vapour

The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.

09 March 2017 - Characterising novel tobacco heating products: a 5-step approach

5-step approach to establishing whether tobacco is being combusted or heated in a tobacco-heating product (THP) is proposed.

08 March 2017 - Award-winning research collaboration featured in special issue of Applied In Vitro Toxicology

Two new Adverse Outcome Pathways (AOPs), developed jointly by British American Tobacco (BAT) and Philip Morris International (PMI), are featured in a special issue of Applied In Vitro Toxicology (AIVT) focusing on the in vitro evaluation of next-generation nicotine products.

03 March 2017 - ‘Bespoke’ study designs central to assessment of next-generation products, BAT scientists tell NAS

Dr Marianna Gaca and Dr James Murphy were both invited to present at the National Academy of Sciences in Washington DC last week, at a committee reviewing the health effects of Electronic Nicotine Delivery Systems (ENDS).

06 February 2017 - Exposure to e-cigarette vapour causes limited impact on gene and protein expression in human lung cells

New research reveals changes in the expression levels of 123 genes when reconstituted lung tissue was exposed to cigarette smoke, compared to only two genes that could be confirmed following exposure to an e-cigarette (Vype ePen) aerosol.

15 December 2016 - ‘Lung-in-the-lab’ shows e-cigarette vapour does not cause DNA damage in human cells

E-cigarette vapour does not damage DNA, even at doses 28 times that of equivalent smoke exposure.

13 December 2016 - E-cigarettes vapour does not cause DNA mutations in lab tests

Several studies have compared the impact of e-cigarette vapour with that of cigarette smoke on cells and found that vapour has little or no effect.

09 December 2016 - e-cigarettes: using vaping robots to measure the amount of vapour delivered to lung cells in the lab

New research proves that e-cigarette aerosol droplets are effectively delivered to cell surfaces in lab-based biological tests.

02 December 2016 - E-cigarettes effectively deliver nicotine

New research shows that e-cigarettes are as effective at delivering nicotine as conventional cigarettes, especially when used by experienced vapers.

29 November 2016 - Science & Technology (S&T) 2015 Report wins 'Most Impressive Public Service Initiative'

BAT has won the award for the ‘Most Impressive Public Service Initiative’ at the Global Tobacco and Nicotine Forum (GTNF) conference in Brussels.

24 November 2016 -  IONTOX and British American Tobacco announce collaboration to develop Lung-Liver-Lung model

US-based biotech company IONTOX and British American Tobacco have entered into a collaboration to develop a lung-liver-lung model with a simulated blood system to study the impact of tobacco and nicotine products on lung health.

11 October 2016 - BAT develops and applies novel test to examine vaping behaviour

Understanding vaping behaviour is an essential first step towards understanding how vaping products are being used by consumers and the potential they may have to reduce harm caused by smoking.

03 October 2016 - E-cigarette vapour is less harmful to lung cells than cigarette smoke

Recent tests conducted by scientists at British American Tobacco (BAT) show that, in stark contrast to cigarette smoke, vapour from the commercially available e-cigarette Vype ePen is less toxic to, and does not cause oxidative stress1 in, human lung cells.

19 September 2016 - Toxicant levels in Vype ePen emissions are on average 92-99% less compared to smoke

A comparison between the vapour from Vype ePen – a commercially available e-cigarette – and 3R4F – a reference cigarette – revealed substantial reductions in the e-Pen’s emissions for all toxicant groups measured.

22 July 2016 - Global standards for vaping products essential to promote innovation

Against a backdrop of a growing number of e-cigarette users globally*, British American Tobacco (BAT) is leading efforts to develop and harmonise standards around vaping products to further reassure consumers of these products potential in reducing the harm from smoking.

18 June 2016 - Advancing scientific research requires an independent, critical yet open approach

A culture of greater—not less— transparency in tobacco and tobacco-industry funded research is needed if we are to realise the reduced risk potential of e-cigarettes and other next generation products.

View more 

Recent Conferences

17 June 2016 - Global Forum on Nicotine (GFN)

04 April 2016 - FDA Workshop on Biomarkers of Potential Harm

04 April 2016 - Institute for In Vitro Sciences Workshop (IIVS)

13 March 2016 - Society of Toxicology (SOT)

2 March 2016 - Society for Research on Nicotine and Tobacco (SRNT)

27 January 2016 - Systems Toxicology - Real World Applications and Opportunities (SYTOX)

27 January 2016 - International Symposium on Capillary Chromatography (ISCC)

View recent and upcoming conferences